Recon: Biogen withdraws EU application for Aduhelm; US aims to make Pfizer’s COVID pill widely available

Recon

ReconJoanne S. Eglovitch

Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy